These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6859073)

  • 41. The use of vasodilator agents in the treatment of heart failure.
    Lloyd EA
    S Afr Med J; 1979 Nov; 56(20):787-95. PubMed ID: 159502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral vasodilator therapy for chronic heart failure: a plea for caution.
    Packer M; Meller J
    Am J Cardiol; 1978 Oct; 42(4):686-9. PubMed ID: 358821
    [No Abstract]   [Full Text] [Related]  

  • 43. Vasodilators in the management of acute heart failure.
    Elkayam U; Janmohamed M; Habib M; Hatamizadeh P
    Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure.
    Franciosa JA; Blank RC; Cohn JN
    Am J Med; 1978 Feb; 64(2):207-13. PubMed ID: 629269
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study.
    Packer M; Medina N; Yushak M; Lee WH
    Am Heart J; 1985 Jun; 109(6):1293-9. PubMed ID: 3890506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A reappraisal of nitrate therapy.
    Abrams J
    JAMA; 1988 Jan; 259(3):396-401. PubMed ID: 3275814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of minoxidil on hemodynamics in patients with congestive heart failure.
    Franciosa JA; Cohn JN
    Circulation; 1981 Mar; 63(3):652-7. PubMed ID: 7006852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preload and afterload without anguish: a simplified framework.
    Mandell HN; Deglin SM
    Postgrad Med; 1982 May; 71(5):105-12. PubMed ID: 6803231
    [No Abstract]   [Full Text] [Related]  

  • 50. Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.
    Armstrong PW
    Can Med Assoc J; 1979 Oct; 121(7):913-8. PubMed ID: 497982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Physiopathologic and pharmacodynamic rationale for the use of nitrate compounds in cardiac decompensation].
    Geraci E
    G Ital Cardiol; 1996 Sep; 26(9):1073-7. PubMed ID: 9036048
    [No Abstract]   [Full Text] [Related]  

  • 52. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
    Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
    Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hemodynamic guidelines in the treatment of acute myocardial infarction by means of vasodilators].
    Zilcher H
    Acta Med Austriaca Suppl; 1979; 15():1-34. PubMed ID: 161946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Provocation of myocardial ischemic events during initiation of vasodilator therapy for severe chronic heart failure. Clinical and hemodynamic evaluation of 52 consecutive patients with ischemic cardiomyopathy.
    Packer M; Meller J; Medina N; Yushak M; Gorlin R
    Am J Cardiol; 1981 Nov; 48(5):939-46. PubMed ID: 7304442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tolerance to organic nitrates: clinical and experimental perspectives.
    Armstrong PW; Moffat JA
    Am J Med; 1983 Jun; 74(6B):73-84. PubMed ID: 6859074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
    Chow MS
    Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Do vasodilators help in chronic heart failure?].
    Slany J
    Wien Klin Wochenschr; 1987 Mar; 99(5):139-44. PubMed ID: 2883777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of transdermal nitroglycerin in the treatment of coronary heart disease.
    Taylor SH
    Am Heart J; 1986 Jul; 112(1):197-207. PubMed ID: 3088957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.